4basebio PLC carries a market capitalization of 92.91M, placing it among publicly traded companies globally.
| Market Cap | 92.91M |
| Enterprise Value | N/A |
4basebio PLC's stock has declined approximately -47.36842% over the past 52 weeks. The 50-day moving average sits at 5.70, while the 200-day moving average is 6.61.
| Beta (5Y) | N/A |
| 52-Week Price Change | -47.36842% |
| 50-Day Moving Average | 5.70 |
| 200-Day Moving Average | 6.61 |
| Average Volume (20 Days) | N/A |